Join

Compare · RVTY vs SEER

RVTY vs SEER

Side-by-side comparison of Revvity Inc. (RVTY) and Seer Inc. (SEER): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both RVTY and SEER operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • RVTY is the larger of the two at $14.36B, about 132.3x SEER ($108.5M).
  • Both names hit the wire about 5 times in the past 4 weeks.
  • RVTY has more recent analyst coverage (21 ratings vs 8 for SEER).
MetricRVTYSEER
Company
Revvity Inc.
Seer Inc.
Price
-
-
Market cap
$14.36B
$108.5M
1M return
-
-
1Y return
-
-
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NYSE
NASDAQ
IPO
2020
News (4w)
5
5
Recent ratings
21
8
SEER

Seer Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Discovery Life Sciences, LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Latest RVTY

Latest SEER